Log in or Sign up for Free to view tailored content for your specialty!
HIV/AIDS News
Lawmakers reauthorize PEPFAR for 1 year as part of spending package
The U.S. House of Representatives reauthorized the U.S. President’s Emergency Plan for AIDS Relief for 1 year as part of a spending package passed on Friday, sending the plan to the Senate for consideration.
EHR-based intervention increases PrEP initiation among some primary care patients
Use of an electronic health record-based intervention significantly increased PrEP use among patients of primary care physicians who care for people with HIV, a randomized trial found.
National HIV self-testing program finds high demand, many testing for first time
DENVER — A national HIV self-testing program found high demand for tests, with many participants testing for the first time, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
‘Essential first step’: HIV study demonstrates potential of long-acting ART in Africa
DENVER — Long-acting ART was shown to be safe and effective in a study conducted in sub-Saharan Africa — an “essential first step” in demonstrating its potential use to treat HIV on the continent, an expert said.
COVID-19 hybrid immunity more protective than vaccination alone among people with HIV
DENVER — Among people with HIV, hybrid immunity against COVID-19 is more effective at preventing infection and severe disease than vaccination alone, according to a study.
VIDEO: People who struggle with daily HIV regimen should be offered long-acting injections
DENVER — People with HIV who have challenges adhering to a daily oral regimen should be offered long-acting formulations of ART, study findings suggest.
Precautions could have prevented HIV cases linked to ‘vampire facials’
DENVER — HIV infections linked to “vampire facials” performed at a spa in New Mexico could have been avoided if the now-closed spa had adhered to appropriate infection prevention and control practices, experts said.
Four children achieve treatment-free HIV remission for 1 year
DENVER — Four children born with HIV who initiated ART within 48 hours of delivery later remained in treatment-free remission for over a year after ART was paused, researchers reported.
Semaglutide can reduce severity of liver disease in people with HIV, study shows
DENVER — A low weekly dose of semaglutide can safely minimize what used to be called nonalcoholic fatty liver disease in people with HIV, a first-of-its-kind study found.
Injectable ART given every 8 weeks safely suppresses HIV in adolescents
DENVER — Long-acting injectable ART administered every 8 weeks safely suppresses HIV in adolescents, according to research presented at the Conference on Retroviruses and Opportunistic Infections.
-
Headline News
CDC outlines six steps hospitals can take to address burnout
March 19, 20242 min read -
Headline News
FDA approves aprocitentan for treatment of hypertension in adults with uncontrolled BP
March 20, 20241 min read -
Headline News
Elinzanetant significantly reduces menopausal hot flash frequency
March 20, 20242 min read
-
Headline News
CDC outlines six steps hospitals can take to address burnout
March 19, 20242 min read -
Headline News
FDA approves aprocitentan for treatment of hypertension in adults with uncontrolled BP
March 20, 20241 min read -
Headline News
Elinzanetant significantly reduces menopausal hot flash frequency
March 20, 20242 min read